Search

Filters

Clear Filters
5:10 PM - 5:20 PM ET

133 - Efficacy and Safety of Targeted-Immunotherapy with or without Stereotactic Ablative Radiotherapy for Recurrent/Metastatic Renal Cell Carcinoma: The Final Result of a Multicenter Ambidirectional cohort study
Speaker: Hu, Ke, MD - Peking University First Hospital, Beijing, Beijing
5:20 PM - 5:30 PM ET

134 - Safety and Efficacy of Stereotactic Body Radiotherapy (SBRT) for Localized Renal Pelvic and Ureteral Carcinoma
Speaker: Li, Xiaoying, MD - Peking University First Hospital, Beijing, Beijing
5:30 PM - 5:40 PM ET

135 - 68Ga-NY096 CAIX PET/CT Eliminates Decision Uncertainty and Refines Systemic Therapy-Radiotherapy Integration In Metastatic ccRCC (NYCRRT)
Speaker: Ma, Mingwei, MD - Peking University First Hospital, Beijing, Beijing
5:40 PM - 5:50 PM ET

136 - Locoregional Recurrence in pT3-4/pN+ Muscle-Invasive Bladder Cancer Receiving Modern Perioperative Systemic Therapy: A Propensity Score-Matched Competing Risk Analysis
Speaker: Cheng, Tian, MD, MBBS - Peking University First Hospital, Beijing, Beijing
5:50 PM - 6:00 PM ET

137 - Adaptive Radioresistance in Muscle-Invasive Bladder Cancer Is Driven by Tumour-Microenvironment Co-Evolution and Enables Biomarker-Guided Radiotherapy
Speaker: Choudhury, Ananya, PhD, MA MRCP FRCR - The Christie NHS Foundation Trust and University of Manchester, Manchester, Greater Manchest
5:00 PM - 5:10 PM ET

138 - State Paid Family Leave Policies, Informal Family Caregivers and Cancer Mortality among Older Adults
Speaker: Barnes, Justin, MD, MS - Mayo Clinic Alix School of Medicine, Rochester, MN
5:10 PM - 5:20 PM ET

139 - Characterization of Laboratory Eligibility Criteria In Phase III Oncology Trials: A Meta-Epidemiological Analysis
Speaker: Pocha, Olivia, MS, BS - Tulane University School of Medicine, New Orleans, LA
5:20 PM - 5:30 PM ET

140 - Endocrine Therapy Adherence after RT Omission in Estrogen Receptor-Positive Early-Stage Breast Cancer
Speaker: Jiang, Shannon, MD - Washington University/B-JH/SLCH Consortium, St. Louis, MO
5:30 PM - 5:40 PM ET

141 - Overall Survival in Oncology Phase III Trials: An Individual Patient Level Meta-Analysis (OPTIMA)
Speaker: Sherry, Alexander, MD - Mayo Clinic Rochester, Rochester, MN
5:40 PM - 5:50 PM ET

142 - Surveying the Valley of Death: How Wide is the Gap between Basic Science and Clinical Application in Radiation/Immunotherapy Research?
Speaker: Groszkiewicz, Abigail, MD - University of Pittsburgh Medical Center, Pittsburgh, PA
5:00 PM - 5:10 PM ET

143 - Computationally Efficient Low Field MRI Enhancement via Foundation Model Feature Engineering
Speaker: Liu, Lianli, PhD - Stanford University, Stanford, CA
5:10 PM - 5:20 PM ET

144 - Single-CT Simulation for Surface-Guided DIBH Radiotherapy Using Deep Learning-Synthesized 3D Body Contours from Scout Images
Speaker: Huh, Yoonsuk, PhD - Seoul National University Hospital, Seoul, Mapo-Gu